Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.
By N. Levitan, A. Dowlati, S. Remick, H. Tahsildar, L. Sivinski, R. Beyth, A. Rimm. 1999
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. F. Timp
- S. Braekkan
- H. Versteeg
- S. Cannegieter
- C. Francis
- Slobodan Vucetic
- Tian Bai
- Shanshan Zhang
Citations in the corpus
- Interpretable Representation Learning for Healthcare via Capturing Disease Progression through Time (2018, methodology): “For example, EHR data have been widely used in various healthcare research tasks such as risk prediction [15, 16, 33], retrospective epidemiologic studies [17, 26, 29] and phenotyping [12, 31].”
- Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients (2008, background): “However, to our knowledge, prior studies of hospitalized patients have not separately evaluated the risk in patients receiving chemotherapy.(8,12) In our current analysis, chemotherapy was indeed a significant risk factor for developing VTE (adjusted OR of 1.”
- Incidence of venous thromboembolism and its effect on survival among patients with common cancers. (2006, unknown): “Prostate 50 926 0 70 33 383 (66) 7041 (14) 3515 (7) 6987 (14) Breast 44 744 99 62 27 014 (60) 13 629 (30) 2029 (5) 2072 (5) Lung 45 215 45 69 6558 (15) 8775 (19) 22 486 (50) 7396 (16) Colon/rectum 32 157 50 71 10 623 (33) 12 766 (40) 6409 (20) 2359 (7) Melanoma 9930 44 55 8065 (81) 431 (4) 466 (5) 9”
- The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality (2005, background): “A prospective cohort study reported malignancies of the kidney, stomach, pancreas, brain, ovary, and lymphoma as being associated with the highest incidence of venous thrombosis.(19) Although our study is a large population-based, case-control study, certain types of malignancy were not found in con”
- Epidemiology of cancer-associated venous thrombosis. (2013, background): “Overall, pancreas, brain, lung and ovarian cancer are reported to induce highest risks.[11,13,17,20] In the literature high risks are additionally reported for lymphomas, myeloma and kidney, stomach and bone cancer.”